Fujifilm has acquired the digital pathology technology assets of Inspirata. The digital pathology offerings, customers and employees of Inspirata will move to Fujifilm. Terms of the deal were not disclosed.
Inspirata’s Dynamyx is an end-to-end digital pathology solution using whole-slide images to digitize patient results. The software capabilities are typically implemented within more extensive medical facilities handling large volumes of pathological images across several lab locations.
Japan-based Fujifilm provides imaging, information and document solutions.
According to the LevinPro HC database, this was the 128th Laboratories, MRI and Dialysis deal of 2022, This compares with 124 Laboratories, MRI and Dialysis transactions reported in 2021.
